Ilhwa North America Inc., a wholly owned U.S. subsidiary of Korea's groundbreaking ginseng company, Il Hwa Co Ltd, introduced a high-absorption ginseng extract utilizing a patented high-yield enzyme-fermented process at Engredea 2012 in March. This breakthrough technology won the Editor’s Choice Award for Best Botanical from Functional Ingredients, the official magazine of Engredea. The unique ginseng extract promises to be a game changer in the ingredient market by delivering higher efficacy, consistent absorption, improved taste profile and lower cost per use.
"We were proud to announce yet another important breakthrough in ginseng technology," said David C. Konn, president of Ilhwa North America. "Our researchers have found a way to resolve the three most important concerns of manufacturers and formulators with ginseng: increased efficacy, better taste and lower cost. We were honored and excited win Engredea’s prestigious Best Botanical 2012 award."
Il Hwa Co Ltd. is a high-tech pharmaceutical and nutraceutical company with three divisions: Ginseng, Pharmaceuticals and Beverages. Through continuous scientific research and development for more than four decades, Ilhwa has become the world leader in ginseng science. The company is fully KFDA compliant and GMP and ISO certified, holding numerous patents and the publications of hundreds of papers and clinical studies. In 2011, Ilhwa received KFDA approval for a "certified health claim" on its new enzyme-fermented ginseng extract: "helps to manage blood glucose.” Ilhwa is the first ginseng company to receive this certification.
Konn continued, "It is the ideal time for Ilhwa to begin Ilhwa North America Inc., as we introduce our patented high-absorption ginseng extract called GinST 15. With offices in New York, Florida and Nevada, our U.S. corporation will enable us to provide world-class direct service and collaboration for our customers in North America. Our company is driven by a single passion: to bring wellness to humanity across the globe through this incredible herb."
"We call GinST 15 the ‘21st Century Ginseng Extract.’ We are confident that it will be a game changer in the ingredient market. Ginseng has long been a valuable ingredient for the functional food and nutraceuticals markets. However, manufacturers and formulators have had problems with ginseng taste, consistent efficacy, and cost. GinST 15 solves all three problems. Also, since it is coming from the world leader in ginseng science and it is clinically proven and patented; manufacturers and formulators can trust it."
GinST 15 utilizes several advances developed by the Il Hwa research team. "Our patented technology increases the delivery of the ginseng to be 15 times more absorbable in the bloodstream—and it speeds the rate of absorption to be four times faster and have three times more consistent absorption," Konn said.
Il Hwa North America hosted a special introductory exhibit at Nutracon in Anaheim, Calif., on March 7 and 8. That exhibit was followed by Engredea on March 9- 11, and now at SupplySide MarketPlace May 9 and 10 at the Javits Center in New York City.
Media, formulators and nutrition professionals are welcome to attend, and learn how one of the world's oldest herbs is now even more usable in their products and formulations, thanks to the breakthroughs of the GinST 15 developers. David Konn will be doing a special speaking engagement at SupplySide MarketPlace Wednesday at 9 a.m.